PMID: 6160352Jan 1, 1981Paper

The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration

Journal of Cardiovascular Pharmacology
J A DominicR G McAllister

Abstract

The pharmacokinetics of verapamil were determined in 8 normal male subjects (age range, 24-28 years) after administration of 0.2 mg/kg over a 3-4 min period. Plasma drug concentrations were measured by a gas-chromatographic method using a nitrogen-specific detector with a sensitivity of 5 ng/ml. Verapamil levels fell in a biexponential pattern, and the data were fitted to a two-compartment model with the NONLIN computer program. The distribution phase half-life was 3.51 min and that of the elimination phase, 110.5 min; the volume of distribution was 178 +/- 26 liters, and the plasma clearance ws 1.06 +/- 0.27 liters/min. The P-R interval of the surface electrocardiogram was increased in each subject in direct proportion to the verapamil plasma level, but with considerable between-subject variability. One subject developed transient Mobitz I block at a plasma drug concentration of 162 ng/ml. At peak verapamil concentrations, mean T-wave amplitude decreased 35 +/- 11% from control height. The results of this study suggest that P-R interval prolongation can be used as an indication of verapamil effect in patients with sinus rhythm.

Citations

Jan 1, 1991·Journal of Clinical Pharmacology·P K ZachariahR L Smith
Dec 1, 1994·Journal of Clinical Pharmacology·D L Keefe
Jan 1, 1985·European Journal of Clinical Pharmacology·R PadriniM Ferrari
Jan 1, 1991·Cancer Chemotherapy and Pharmacology·R T Dorr, J D Liddil
Jan 1, 1983·Pharmacology & Therapeutics·W G Nayler, J D Horowitz
Jan 17, 2002·The New England Journal of Medicine·M B MurphyG D Shorten
Jan 1, 1985·European Journal of Clinical Pharmacology·J MooyK H Rahn
Nov 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·W M BennettI Singer
Sep 1, 1982·Progress in Cardiovascular Diseases·R G McAllister
Aug 1, 1982·American Heart Journal·J B SchwartzD C Harrison
Oct 1, 1982·The American Journal of Cardiology·M J ReiterE L Pritchett
Mar 4, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Seigo SanohShigeru Ohta
Aug 24, 2018·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·K G MikeladzeS B Yakovlev
May 1, 1982·Pacing and Clinical Electrophysiology : PACE·W H Frishman, T H LeJemtel
Oct 1, 1993·Biopharmaceutics & Drug Disposition·P Manitpisitkul, W L Chiou
Jul 1, 1983·Biopharmaceutics & Drug Disposition·R G McAllisterM T Piascik
Jun 25, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Rafael J Ruiz-SalmerónAmadeo Betriu
Mar 1, 1989·The International Journal of Neuroscience·R E HicksC J Clayton
Mar 10, 1988·The New England Journal of Medicine·R H FalkS Manaker
Jan 1, 1985·Acta Pharmacologica Et Toxicologica·P Hermann, P L Morselli
Jan 1, 1986·Acta Pharmacologica Et Toxicologica·P Anderson
Jun 1, 1982·Drug Intelligence & Clinical Pharmacy·M T McMahon, S L Sheaffer
Jan 1, 1984·Acta Medica Scandinavica. Supplementum·L StorsteinL Saevareid
Oct 14, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·F A BrightmanS Thomas
Feb 9, 2021·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Anselm WongUNKNOWN EXTRIP workgroup
Aug 9, 1985·Journal of Chromatography·U A ShuklaW D Ensminger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.